LIVE

Serial Number

97977473

Owner

Santhera Pharmaceuticals (Schweiz) AG

Attorney

Patrick J. Concannon

First Use Date

Jun 22, 2023

Filing Date

Oct 19, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SANTHERA Trademark

Serial Number: 97977473 • Registration: 7357364

SANTHERA is a trademark filed by Santhera Pharmaceuticals (Schweiz) AG on October 19, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Santhera Pharmaceuticals (Schweiz) AG (13 trademarks)

Hammerstrasse 47
4410 Liestal , CH

Entity Type: 03

Legal Representation

Attorney of Record

Patrick J. Concannon

2,292 trademarks filed View all →

Trademark Details

Filing Date

October 19, 2022

Registration Date

April 9, 2024

First Use Anywhere

June 22, 2023

First Use in Commerce

June 22, 2023

Published for Opposition

July 4, 2023

Goods & Services

Pharmaceutical preparations for the treatment of neuromuscular diseases, but not in the field of oncology and rheumatoid arthritis

Filing History

REGISTERED-PRINCIPAL REGISTER

Apr 9, 2024 R.PR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 9, 2024 NRCC

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 8, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 7, 2024 CNPR

NOTICE OF DESIGN SEARCH CODE E-MAILED

Feb 16, 2024 MDSC

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 16, 2024 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Feb 15, 2024 SUPC

DIVISIONAL PROCESSING COMPLETE

Feb 15, 2024 DPCC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 12, 2024 AITU

USE AMENDMENT FILED

Jan 30, 2024 IUAF

SOU EXTENSION 1 GRANTED

Jan 30, 2024 EX1G

SOU EXTENSION 1 FILED

Jan 30, 2024 EXT1

DIVISIONAL REQUEST RECEIVED

Jan 30, 2024 DRRR

TEAS REQUEST TO DIVIDE RECEIVED

Jan 30, 2024 ERTD

SOU TEAS EXTENSION RECEIVED

Jan 30, 2024 EEXT

TEAS STATEMENT OF USE RECEIVED

Jan 30, 2024 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 29, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 4, 2023 NPUB

PUBLISHED FOR OPPOSITION

Jul 4, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 14, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 26, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

May 24, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 24, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 24, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 9, 2023 GNRN

NON-FINAL ACTION E-MAILED

Mar 9, 2023 GNRT

NON-FINAL ACTION WRITTEN

Mar 9, 2023 CNRT

ASSIGNED TO EXAMINER

Mar 2, 2023 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 4, 2022 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 3, 2022 NWOS

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

Oct 27, 2022 TAEA

TEAS VOLUNTARY AMENDMENT RECEIVED

Oct 27, 2022 PARI

NEW APPLICATION ENTERED

Oct 22, 2022 NWAP

Related Trademarks

More from this Owner

SANTHERA

RAXONE

AGAMREE

More in Same Class

LEVEL

HY AM

FORMULA INKA

PRODUCT INNOVATION. PATIENT IMPACT.

ZEFYLTI

GILPIN FACIAL PLASTICS